Cerus (CERS) Gross Profit Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cerus | 549.42 Mn | 469.73 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.79% |
| Dec 31, 2025 | 5.27% |
| Sep 30, 2025 | -7.79% |
| Jun 30, 2025 | -29.22% |
| Mar 31, 2025 | 45.49% |
| Dec 31, 2024 | 33.03% |
| Sep 30, 2024 | 20.21% |
| Jun 30, 2024 | -21.63% |
| Mar 31, 2024 | -37.18% |
| Dec 31, 2023 | 82.72% |
| Sep 30, 2023 | 24.62% |
| Jun 30, 2023 | -35.33% |
| Mar 31, 2023 | -44.08% |
| Dec 31, 2022 | 67.93% |
| Sep 30, 2022 | -38.91% |
| Jun 30, 2022 | -24.01% |
| Mar 31, 2022 | -24.48% |
| Dec 31, 2021 | 83.82% |
| Sep 30, 2021 | -41.42% |
| Jun 30, 2021 | -40.33% |
| Mar 31, 2021 | -38.86% |
| Dec 31, 2020 | 87.57% |
| Sep 30, 2020 | -32.99% |
| Jun 30, 2020 | -34.68% |
| Mar 31, 2020 | 5.54% |
| Dec 31, 2019 | 31.14% |
| Sep 30, 2019 | 17.43% |
| Jun 30, 2019 | 21.28% |
| Mar 31, 2019 | 2.62% |
| Dec 31, 2018 | 13.49% |
| Sep 30, 2018 | 14.32% |
| Jun 30, 2018 | -23.16% |
| Mar 31, 2018 | 6.07% |
| Dec 31, 2017 | 5.62% |
| Sep 30, 2017 | 7.24% |
| Jun 30, 2017 | 7.19% |
| Mar 31, 2017 | 0.84% |
| Dec 31, 2016 | 4.14% |
| Sep 30, 2016 | 9.19% |
| Jun 30, 2016 | 9.80% |
| Mar 31, 2016 | 4.89% |
| Dec 31, 2015 | 20.09% |
| Sep 30, 2015 | -1.40% |
| Jun 30, 2015 | -9.70% |